Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis
AI Catrina, CI Svensson, V Malmström… - Nature Reviews …, 2017 - nature.com
A key unanswered question in the pathophysiology of rheumatoid arthritis (RA) is how
systemic autoimmunity progresses to joint-specific inflammation. In patients with seropositive …
systemic autoimmunity progresses to joint-specific inflammation. In patients with seropositive …
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
ER Vossenaar, AJW Zendman, WJ van Venrooij… - …, 2003 - Wiley Online Library
Abstract Peptidylarginine deiminase (PAD, EC 3.5. 3.15) enzymes catalyze the conversion
of protein‐bound arginine to citrulline. This post‐translational modification may have a big …
of protein‐bound arginine to citrulline. This post‐translational modification may have a big …
Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
Objectives Rheumatoid arthritis (RA)-specific anti-citrullinated protein/peptide antibodies
(ACPAs) appear before disease onset and are associated with bone destruction. We aimed …
(ACPAs) appear before disease onset and are associated with bone destruction. We aimed …
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
RG Urdinguio, JV Sanchez-Mut, M Esteller - The Lancet Neurology, 2009 - thelancet.com
Epigenetic mechanisms such as DNA methylation and modifications to histone proteins
regulate high-order DNA structure and gene expression. Aberrant epigenetic mechanisms …
regulate high-order DNA structure and gene expression. Aberrant epigenetic mechanisms …
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
Rheumatoid arthritis (RA) is now clearly a true autoimmune disease with accumulating
evidence of pathogenic disease‐specific autoimmunity to citrullinated proteins. Citrullination …
evidence of pathogenic disease‐specific autoimmunity to citrullinated proteins. Citrullination …
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
S Wang, Y Wang - Biochimica et Biophysica Acta (BBA)-Gene Regulatory …, 2013 - Elsevier
Peptidylarginine deiminases are a family of enzymes that mediate post-translational
modifications of protein arginine residues by deimination or demethylimination to produce …
modifications of protein arginine residues by deimination or demethylimination to produce …
The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α-and β-chains of fibrin
C Masson-Bessiere, M Sebbag… - The Journal of …, 2001 - journals.aai.org
IgG antifilaggrin autoantibodies (AFA) are the most specific serological markers of
rheumatoid arthritis. In epithelial tissues, they recognize citrulline-bearing epitopes present …
rheumatoid arthritis. In epithelial tissues, they recognize citrulline-bearing epitopes present …
Citrullination: a posttranslational modification in health and disease
Posttranslational modifications are chemical changes to proteins that take place after
synthesis. One such modification, peptidylarginine to peptidylcitrulline conversion, catalysed …
synthesis. One such modification, peptidylarginine to peptidylcitrulline conversion, catalysed …
Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase
Objective To map the antibody response to human citrullinated α‐enolase, a candidate
autoantigen in rheumatoid arthritis (RA), and to examine cross‐reactivity with bacterial …
autoantigen in rheumatoid arthritis (RA), and to examine cross‐reactivity with bacterial …
[HTML][HTML] Pre-clinical and clinical implications of “inside-out” vs.“outside-in” paradigms in multiple sclerosis etiopathogenesis
HE Titus, Y Chen, JR Podojil, AP Robinson… - Frontiers in cellular …, 2020 - frontiersin.org
Multiple Sclerosis (MS) is an immune-mediated neurological disorder, characterized by
central nervous system (CNS) inflammation, oligodendrocyte loss, demyelination, and …
central nervous system (CNS) inflammation, oligodendrocyte loss, demyelination, and …